1. Home
  2. SAR vs ALMS Comparison

SAR vs ALMS Comparison

Compare SAR & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAR
  • ALMS
  • Stock Information
  • Founded
  • SAR 2007
  • ALMS 2021
  • Country
  • SAR United States
  • ALMS United States
  • Employees
  • SAR N/A
  • ALMS N/A
  • Industry
  • SAR Investment Managers
  • ALMS
  • Sector
  • SAR Finance
  • ALMS
  • Exchange
  • SAR Nasdaq
  • ALMS NYSE
  • Market Cap
  • SAR 337.6M
  • ALMS 402.6M
  • IPO Year
  • SAR 2007
  • ALMS 2024
  • Fundamental
  • Price
  • SAR $23.43
  • ALMS $5.03
  • Analyst Decision
  • SAR Buy
  • ALMS Strong Buy
  • Analyst Count
  • SAR 4
  • ALMS 7
  • Target Price
  • SAR $25.08
  • ALMS $28.00
  • AVG Volume (30 Days)
  • SAR 88.4K
  • ALMS 410.7K
  • Earning Date
  • SAR 05-07-2025
  • ALMS 05-19-2025
  • Dividend Yield
  • SAR 14.13%
  • ALMS N/A
  • EPS Growth
  • SAR 186.33
  • ALMS N/A
  • EPS
  • SAR 2.02
  • ALMS N/A
  • Revenue
  • SAR $148,855,238.00
  • ALMS N/A
  • Revenue This Year
  • SAR $6.07
  • ALMS N/A
  • Revenue Next Year
  • SAR N/A
  • ALMS N/A
  • P/E Ratio
  • SAR $11.64
  • ALMS N/A
  • Revenue Growth
  • SAR 3.57
  • ALMS N/A
  • 52 Week Low
  • SAR $21.10
  • ALMS $3.18
  • 52 Week High
  • SAR $26.49
  • ALMS $13.53
  • Technical
  • Relative Strength Index (RSI)
  • SAR 44.44
  • ALMS N/A
  • Support Level
  • SAR $22.22
  • ALMS N/A
  • Resistance Level
  • SAR $25.11
  • ALMS N/A
  • Average True Range (ATR)
  • SAR 0.56
  • ALMS 0.00
  • MACD
  • SAR -0.05
  • ALMS 0.00
  • Stochastic Oscillator
  • SAR 37.54
  • ALMS 0.00

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

Share on Social Networks: